Bio Protocol Token Surges 200% on Staking Growth and Institutional Backing

Bio Protocol’s native token, $BIO, has surged over 200% in the last 14 days, driven by a combination of key on-chain developments, strategic partnerships, and high-profile investments. The price increase, from approximately $0.065 to $0.20, was supported by a significant rise in token staking and increased market participation.

The upward momentum began in late July 2025 with the launch of the V2 Launchpad and the introduction of BioXP, a points-based system designed to incentivize staking and community engagement. These upgrades also introduced BioAgents, AI-driven tools intended to automate aspects of scientific research, aligning with Bio Protocol’s focus on decentralized science (DeSci). According to on-chain data, more than 125 million $BIO tokens have been staked, a 400% increase compared to prior levels, which has effectively reduced circulating supply and contributed to price appreciation [1].

The project also gained traction with institutional and retail investors following its listing on Coinbase in July 2025, providing broader accessibility to the token. Additionally, Arthur Hayes, co-founder of BitMEX, reportedly invested $1 million in $BIO, signaling confidence in the project’s potential and further fueling market interest. Binance Labs had previously invested in Bio Protocol in November 2024, adding to the growing list of institutional support [2].

A further catalyst for the price surge was the allocation of $80,000 to a Phase 2 clinical trial focused on brain health and memory improvement. This move reinforced the real-world utility of $BIO, as token holders are directly linked to royalties and intellectual property rights from funded research. The announcement triggered a 25% price jump on the day of the funding news, with trading volumes surpassing $420 million [3].

Volume data also reflects the growing interest in $BIO. Prior to the staking program, the token traded in a narrow range between $0.056 and $0.081 with daily volumes under $100 million. After the launch of the staking program, the price rose to $0.129 and daily volumes spiked to as high as $421 million. This upward trend continued with the price reaching $0.20 and daily volumes surpassing $580 million, approaching the project’s $312 million market cap [4].

Bio Protocol currently supports 12 BioDAOs and has raised over $24.3 million to fund scientific research, with $15 million already deployed. This model of linking token value to biotechnology intellectual property distinguishes it within the DeSci space. The platform has also partnered with VitaDAO, Pfizer Ventures, and Harvard Medical School, strengthening its credibility and ecosystem.

Despite the strong market performance, analysts have not yet issued formal forecasts for the token’s future trajectory, and the recent surge appears to be driven by market sentiment and speculative interest rather than immediate fundamental changes [5].

[1] CoinMarketCap Community Article (https://coinmarketcap.com/community/articles/68a833da3fa6d14fe03f0101/)

[5] Top Crypto Gainers & Losers Today (https://coincodex.com/gainers-losers/)